Flow Cytometry Market worth $7.0 billion by 2028

Flow Cytometry Market in terms of revenue was estimated to be worth $4.7 billion in 2023 and is poised to reach $7.0 billion by 2028, growing at a CAGR of 8.3% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark
Flow Cytometry Market [https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $4.7 billion in 2023 and is poised to reach $7.0 billion by 2028, growing at a CAGR of 8.3% from 2023 to 2028 according to a new report by MarketsandMarkets Trademark .

The growth of this market is driven by the increasing prevalence of chronic diseases and increasing funding for research. Moreover, the launch of novel products in the market by key market players and increased use of flow cytometry in clinical research & diagnostics, such as HIV/AIDS Monitoring, organ transplantation, and cancer diagnostics, are some of the elements propelling the growth of the market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584&utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral]

The Reagents & consumables segment accounted for the largest share of the product & service segment in the flow cytometry market in 2022.

Based on products & services, the flow cytometry market is segmented into software, services, reagents & consumables, instruments, and accessories. Reagents & consumables accounted for the largest share of the flow cytometry market in 2022. The factors attributable to the growth, development of high-quality reagents, increased research activities, and launch of application-specific cytometry reagents.

The Research application segment accounted for the largest share of the application segment in the flow cytometry market in 2022.

Based on applications, the flow cytometry market is segmented into clinical, research and industrial applications. In 2022, the research applications segment accounted for the dominant share in the global flow cytometry market. The dominance of the market is attributable to various factors, such as increased research activities & funding and a rise in industrial & academic collaboration. The clinical applications segment is likely to grow at a significant CAGR owing to the increased adoption of flow cytometry in clinical applications.

North America dominated the flow cytometry market in 2022.

Based on region, the flow cytometry market is segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. In 2022, North America dominated the market, followed by Europe. The presence of key market players in the region and increasing public-private initiatives for research activities are key factors supporting the growth of the North American flow cytometry market. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. The high prevalence of HIV/AIDS & cancer and rising treatment options for target diseases (cancer and immunological disorders) are driving the market growth. Further factors like rising government funding and the strong presence of key players in the region are some of the factors anticipated to contribute to the flow cytometry market growth in the Asia Pacific.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584&utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral]

Key Market Players:

Key players in the flow cytometry market include BD (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Sony Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMerieux (France), Cytonome/ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences (US), Union Biometrica, Inc. (US), Luminex Corporation (Italy), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), (US), Nexcelom Biosciences LLC. (US), BennuBio Inc. (US), Orflo Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands).

Flow Cytometry Market Advantages:

* Multiparameter Analysis: Flow cytometry enables simultaneous analysis of multiple cellular parameters (e.g., size, shape, markers), offering a comprehensive view of complex cell populations and their interactions.
* Single-Cell Resolution: The technology provides insights into individual cells, allowing researchers to study heterogeneity, identify rare cell populations, and understand cellular behavior at a granular level.
* High Throughput: Flow cytometers can analyze thousands of cells per second, facilitating rapid data acquisition and significantly reducing experiment duration.
* Automation and Reproducibility: Integration of automation and robotics ensures consistent and reproducible results, minimizing experimental variations and human errors.
* Cell Sorting: Flow cytometers equipped with cell sorting capabilities enable isolation of specific cell subsets for downstream analysis, transplantation, or further experimentation.
* Functional Analysis: Flow cytometry can assess cellular functions, such as viability, proliferation, apoptosis, and cell cycle progression, providing insights into cell health and behavior.
* Immunophenotyping: Valuable in immunology research, flow cytometry helps characterize immune cell populations, aiding in the understanding of immune responses, diseases, and therapies.
* Drug Discovery: Flow cytometry plays a pivotal role in drug development by assessing drug effects on cells, identifying potential drug candidates, and evaluating drug toxicity.
* Cancer Research: It aids in cancer diagnostics and research by detecting cancer cells, characterizing tumor heterogeneity, and evaluating treatment responses.
* Personalized Medicine: Flow cytometry contributes to personalized medicine by enabling tailored treatments based on individual patient profiles and disease characteristics.
* Advanced Data Analysis: Integration with AI and machine learning enhances data interpretation, uncovering complex patterns and relationships within datasets.
* Portable Systems: Miniaturization of instruments results in portable flow cytometry devices suitable for point-of-care diagnostics, field research, and resource-limited settings.
* Clinical Applications: It's used in clinical laboratories for diagnosing immunological disorders, monitoring disease progression, and assessing treatment efficacy.
* Research Versatility: Flow cytometry finds applications in various fields, including immunology, hematology, microbiology, neuroscience, stem cell research, and more.
* Collaborative Potential: The technology encourages collaboration between researchers, clinicians, and industries, fostering cross-disciplinary advancements.

These pointers highlight the multifaceted advantages of flow cytometry, making it an indispensable tool in scientific research, clinical diagnostics, and healthcare innovation.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=65374584 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=65374584&utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=flow-cytometry-market-worth-70-billion-by-2028]
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html



This release was published on openPR.